This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Dec 20:9:3042.
doi: 10.3389/fimmu.2018.03042. eCollection 2018.

Schistosome Egg Migration: Mechanisms, Pathogenesis and Host Immune Responses

Affiliations
Review

Schistosome Egg Migration: Mechanisms, Pathogenesis and Host Immune Responses

Alice H Costain et al. Front Immunol. .

Erratum in

Abstract

Many parasitic worms possess complex and intriguing life cycles, and schistosomes are no exception. To exit the human body and progress to their successive snail host, Schistosoma mansoni eggs must migrate from the mesenteric vessels, across the intestinal wall and into the feces. This process is complex and not always successful. A vast proportion of eggs fail to leave their definite host, instead becoming lodged within intestinal or hepatic tissue, where they can evoke potentially life-threatening pathology. Thus, to maximize the likelihood of successful egg passage whilst minimizing host pathology, intriguing egg exit strategies have evolved. Notably, schistosomes actively exert counter-inflammatory influences on the host immune system, discreetly compromise endothelial and epithelial barriers, and modulate granuloma formation around transiting eggs, which is instrumental to their migration. In this review, we discuss new developments in our understanding of schistosome egg migration, with an emphasis on S. mansoni and the intestine, and outline the host-parasite interactions that are thought to make this process possible. In addition, we explore the potential immune implications of egg penetration and discuss the long-term consequences for the host of unsuccessful egg transit, such as fibrosis, co-infection and cancer development.

Keywords: Schistosoma mansoni; endothelium; immune modulation; intestine; type 2 immunity.

PubMed Disclaimer

Figures

Figure 1
Figure 1
An overview of S. mansoni egg migration. Schistosome egg transit is facilitated by a series of host interactions at the intestinal and vascular interface. (A) The development of schistosomes into sexually mature, egg-producing adults occurs within the portal vein (~3–5 weeks post infection) and requires the transduction of host-derived signals (including those from the innate and adaptive immune system) to the developing worm pair. Once sexual maturity is reached, worm pairs migrate toward the mesenteric vessels, where the females lay approximately 300 eggs per day and actively modulates the intravascular environment to support their long-term survival. The production of eggs at ~5–6 weeks post infection is a milestone event in the schistosome life cycle, that is characterized by induction of a marked Th2 response and angiogenesis. Notably, the generation of a Th2 response by the host is critical for egg passage, and new vessel formation may favor egg transit, promoting the recruitment of immune cells and nutrients to developing granulomas. Freshly deposited eggs cannot move by themselves and must somehow attach and extravasate the endothelium. Although yet to be fully defined, this process may involve E-selectin:-Lewis-x interactions, and participation from platelets, ICAM-1 and VCAM-1. While a large proportion of eggs successfully penetrate the endothelium and reach intestinal tissue, many are swept to the liver or other distal locations (e.g., brain or spinal cord). Since schistosome eggs are unable to transit through these organs, overwhelming tissue pathology and inflammation may ensue. (B) Once schistosome eggs have passed across the host endothelium and out of the vasculature, they must cross the multi-layered intestinal wall. The host immune system responds to transiting eggs via an inflammatory granuloma response, in which individual eggs are encapsulated by immune cells [including alternatively activated (AA) macrophages, Th2 cells and eosinophils] and extracellular matrix (ECM), which protects host tissues from egg-derived toxins, but ultimately leads to formation of fibrotic lesions. For unknown reasons, granulomatous responses need to successfully develop for effective egg excretion from the host. Accordingly, schistosomes and their host have co-evolved a wide range of mechanisms to skew the host immune response toward granuloma-inducing Th2 profile. These include the ability of soluble egg antigens (SEA) to promote alternative activation in macrophages and to condition dendritic cells (DCs) for Th2 polarization. However, to prevent unwanted bystander tissue damage and potentially fatal immunopathology, schistosomes also implement various strategies to dampen host immunity and expanded regulatory networks (Bregs and Tregs). There remain many unknowns surrounding egg migration. This includes the molecules secreted by eggs to disrupt host barriers and modulate immune responses and, importantly, how egg penetration and intestinal ‘leakiness' may influence local and systemic immune reactions.
Figure 2
Figure 2
S. mansoni egg penetrating through the intestinal wall. Light microscope image of Masson's Trichrome stained ileal section (5 μm) from a C57BL/6 mouse 6 weeks after percutaneous infection with approximately 40 S. mansoni cercariae.

References

    1. Warren KS, Mahmoud AA, Cummings P, Murphy DJ, Houser HB. Schistosomiasis mansoni in Yemeni in California: duration of infection, presence of disease, therapeutic management. Am J Trop Med Hyg. (1974) 23:902–9. 10.4269/ajtmh.197423902 - DOI - PubMed
    1. Skelly PJ, Da'dara AA, Li XH, Castro-Borges W, Wilson RA. Schistosome feeding and regurgitation. PLoS Pathog. (2014) 10:e1004246. 10.1371/journal.ppat.1004246 - DOI - PMC - PubMed
    1. Moore DV, Sandground JH. The relative egg producing capacity of Schistosoma mansoni and Schistosoma japonicum. Am J Trop Med Hyg. (1956) 5:831–40. 10.4269/ajtmh.19565831 - DOI - PubMed
    1. Fan PC, Kang YC. Egg production capacity of one-pair worms of Schistosoma japonicum in albino mice. Southeast Asian J Trop Med Public Health (2003) 34:708–12. - PubMed
    1. Hams E, Aviello G, Fallon PG. The Schistosoma granuloma: friend or foe? Front Immunol. (2013) 4:89 10.3389/fimmu.2013.00089 - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

Full text links
Frontiers Media SA full text link Frontiers Media SA Free PMC article
Cite

AltStyle によって変換されたページ (->オリジナル) /